Cervical Cancer Diagnostics Market by Type of Test (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage, Cone Biopsy and Loop Electrosurgical Excision Procedure) and Forecast 2017-2021

Cervical Cancer Diagnostics Market by Type of Test (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage, Cone Biopsy and Loop Electrosurgical Excision Procedure) and Forecast 2017-2021

Cervical cancer is one of the most common cancers in women worldwide. Cervical cancer occurs when abnormal cells on the cervix grow out of control. Most cervical cancer is caused by a virus called human papillomavirus or HPV. The virus spreads through sexual contact. It is a malignant tumor of the lower most part of the uterus (womb) that can be prevented by PAP smear screening and a HPV vaccine. A woman with a persistent HPV infection is at greater risk of developing cervical cell abnormalities and cancer than a woman whose infection resolves on its own.

The global cervical cancer diagnostics market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).

The global cervical cancer diagnostics market segmentation is based on type of test (pap smear tests, colposcopy, HPV testing, endocervical curettage, cone biopsy and loop electrosurgical excision procedure).

The global cervical cancer diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global cervical cancer diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global cervical cancer diagnostics market and included in this report are Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics, Inc., QIAGEN N.V., Femasys, Inc., Zilico Ltd., Guided Therapeutics, Inc., OncoHealth Corp.

  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue US$ Million, 2014-2021)
    • Forecast Estimation (Revenue US$ Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Products
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Diagnostic Test Type
    • Indication or Infection Type
    • Technology
    • Diagnostics Application
    • Service Type
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Cervical Cancer Diagnostics Market

1. Test Type
1.1 Pap Smear Test
1.2 Colposcopy
1.3 HPV Test
1.4 Endocervical Curettage (ECC)
1.5 Others (Cone biopsy and Loop Electrosurgical Excision Procedures, etc.)

2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World

3. Company Profiles
3.1 Abbott Laboratories
3.2 Becton, Dickinson and Company
3.3 Hologic, Inc.
3.4 F. Hoffmann-La Roche Ltd.
3.5 Quest Diagnostics, Inc.
3.6 QIAGEN N.V.
3.7 Females, Inc.
3.8 Zilico Ltd.
3.9 Guided Therapeutics, Inc.
3.10 OncoHealth Corporation

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*